Bosch expands pharmaceutical portfolio
From sachets up to insulin pens and folding cartons – Bosch provides a comprehensive machine range for all packaging steps.
New solutions for the packaging process.
Bosch Packaging Technology has expanded its expertise in the nonaseptic packaging process for pharmaceuticals. Following the introduction of the Sigpack TTMP topload cartoner for pharmaceutical products, the company has added two further machines to its portfolio: the Sigpack VPF vertical flat pouch machine and the horizontal flow wrapping machine Sigpack HML. “Our new machines ideally complement the portfolio of Bosch Packaging Technology. We offer our customers from the pharmaceutical industry reliable and efficient solutions from a single source that can cover the entire production and packaging process,” says Dr Christian Walti, general manager at the Bosch Packaging Technology site in Beringen.
New powder solution offers high flexibility
The new vertical flat pouch machine Sigpack VPF was developed especially for the packaging of powders. Pain killers in powder form are amongst the products typically filled into sachets. Thanks to the innovative sealing technology from Bosch, the machine produces hermetically sealed packages, which safely protect the product. The VPF allows manufacturers to flexibly expand their sachet production by up to twelve lanes. The pouch size can also be quickly and easily adapted according to customer requirements. Thanks to the high dosing accuracy and excellent sealing properties, the machine can produce and fill up to 1 500 sachets per minute precisely and at the highest quality.
In September 2016, the Sigpack VPF received the German Packaging Award from the German Packaging Institute (DVI) in the category packaging machinery.
Compact horizontal flow wrapping machine for hermetic packaging
Bosch further extends its portfolio by a compact horizontal flow wrapping machine, which can either be loaded independently or integrated seamlessly into a complete line. The Sigpack HMUL or HML is available either with ultrasonic or heat sealing technology. “The new flow wrapping machine achieves an output of between 200 and 350 products per minute and is suited for the hermetic packaging of various pharmaceutical products such as vial cards or inhalers. The open machine design enables a quick line clearance, thus ensuring high process safety,” says Daniel Bossel, head of product management at Bosch Packaging Technology.
Flexible solutions for complete lines from a single source
With the expanded machine portfolio, Bosch now offers packaging solutions for every production step from a single source – for example for the treatment of diabetes. Insulin can be produced with bioreactors from Bosch, subsequently filled into cartridges and assembled to insulin pens on further Bosch equipment. CIP/SIP cleaning systems and sterilization equipment can also be integrated into the production process. With the new machine range, manufacturers now also have the possibility to hermetically package the insulin pens into flow wraps. End-of-line solutions such as the Sigpack TTMP cartoner round off Bosch’s line competence. “The modular design of our machines enables manufacturers to individually equip their production lines and add further Bosch equipment. For instance, serialization solutions make each step traceable – from the single pack right through to pallets,” explains Walti. “This way, our customers receive a consistent, user-friendly concept for their entire packaging process."
Related News
-
News Pharmaceutical Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain.
-
News Merck KGaA to buy US biotech SpringWorks for US$3.9 billion
The German multinational pharmaceutical company Merck KGaA have signed a deal to buy US biotech company SpringWorks Therapeutics at an equity value of US$3.9 billion in a move to add rare cancer therapeutics to their pipelines.
-
News Cassava Sciences halts Alzheimer's drug trial after limited progress
Cassava Sciences have drawn a close to their investigations and development of the drug simufilam, which they intended to be used for the treatment of Alzheimer’s disease.
-
News US FDA adds haemodialysis bloodlines to devices shortage list
On March 14, 2025, the US FDA published an open letter to healthcare providers citing continuing supply disruptions of haemodialysis bloodlines, an essential component of dialysis machines.
-
News Vertex Pharmaceuticals stock jumps as FDA approves non-opioid painkiller
UK-based Vertex Pharmaceuticals saw their stock shares soar as the US FDA signed off on the non-opioid painkiller Journavx, also known as suzetrigine, for patients with moderate to severe acute pain, caused by surgery, accidents, or injuries.
-
News Lessons from CPHI Milan 2024: Sunny Intervals for Pharma Manufacturing?
As the 2024 CPHI conference wrapped up in Milan, we caught up with L.E.K. Consulting – a global strategy consulting firm with deep expertise in pharma manufacturing – to discuss evolving market perspectives and business outlook. -
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement.